biparatopic TROP2 antibody drug conjugate (RemeGen Biosciences)

N/A

Report date: 2025/06/11 10:45:49

Base Information

Drug Namebiparatopic TROP2 antibody drug conjugate (RemeGen Biosciences)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate

Mechanisms of ActionTumor-associated calcium signal transducer 2 modulatorsDNA topoisomerase I inhibitors

TargetsDNA topoisomerase ITumor-associated calcium signal transducer 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRemeGen Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesRemeGen Biosciences Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A